• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红细胞分布宽度与预后营养指数联合对 PCI 患者预后的影响。

The Combination Effect of the Red Blood Cell Distribution Width and Prognostic Nutrition Index on the Prognosis in Patients Undergoing PCI.

机构信息

Department of Emergency, Tianjin Huanhu Hospital, Tianjin 300222, China.

Tianjin Key Laboratory of Ions and Molecular Function of Cardiovascular Diseases, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.

出版信息

Nutrients. 2024 Sep 19;16(18):3176. doi: 10.3390/nu16183176.

DOI:10.3390/nu16183176
PMID:39339776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11434894/
Abstract

BACKGROUND

Inflammation and malnutrition are related to adverse clinical outcomes in patients with coronary artery disease (CAD). However, it is unclear whether there is a relationship between the PNI (prognostic nutritional index) and RDW (red blood cell distribution width) regarding the impact on the prognosis in patients with CAD undergoing percutaneous coronary intervention (PCI).

METHODS

A total of 5605 consecutive CAD patients undergoing PCI were selected retrospectively. The patients were stratified into four groups according to the PNI [high PNI (H-PNI) and low PNI (L-PNI)] and RDW [high RDW (H-RDW) and low RDW (L-RDW)]. The cutoff values of RDW and PNI were calculated using receiver-operating characteristic curve analysis. The primary endpoint was 1-year all-cause mortality (ACM). The secondary endpoint was major adverse cardiac cerebrovascular events (MACCEs), the composite of cardiac death (CD), the recurrence of MI, target lesion revascularization (TLR), and stroke. A Cox proportional hazards model was used to evaluate the association between the PNI, RDW, and clinical endpoints.

RESULTS

During 1-year follow-up, 235 (4.19%) patients died. In multivariate regression analysis, the L-PNI/H-RDW group was found to have the highest risk of 1-year ACM [hazard ratio (HR) = 8.85, 95% confidence interval (CI): 5.96-13.15, = 0.020] with the H-PNI/L-RDW group as a reference, followed by the L-PNI/L-RDW (HR = 3.96, 95% CI: 2.60-6.00, < 0.001) and H-RDW/H-PNI groups (HR = 3.00, 95% CI: 1.99-4.50, < 0.001). Nomograms were developed to predict the probability of 1-year ACM and MACCEs.

CONCLUSIONS

CAD patients with L-PNI and H-RDW experienced the worst prognosis. The combination of PNI and RDW was a strong predictor of 1-year ACM. The coexistence of PNI and RDW appears to have a synergistic effect, providing further information for the risk stratification of CAD patients.

摘要

背景

炎症和营养不良与冠心病(CAD)患者的不良临床结局相关。然而,目前尚不清楚预后营养指数(PNI)和红细胞分布宽度(RDW)之间是否存在关系,以及它们对接受经皮冠状动脉介入治疗(PCI)的 CAD 患者的预后有何影响。

方法

回顾性选择了 5605 例连续的 CAD 患者接受 PCI。根据 PNI[高 PNI(H-PNI)和低 PNI(L-PNI)]和 RDW[高 RDW(H-RDW)和低 RDW(L-RDW)]将患者分为四组。使用受试者工作特征曲线分析计算 RDW 和 PNI 的截断值。主要终点为 1 年全因死亡率(ACM)。次要终点为主要不良心脑血管事件(MACCEs),包括心源性死亡(CD)、MI 复发、靶病变血运重建(TLR)和卒中的复合终点。使用 Cox 比例风险模型评估 PNI、RDW 与临床终点之间的关系。

结果

在 1 年随访期间,有 235 例(4.19%)患者死亡。多变量回归分析发现,与 H-PNI/L-RDW 组相比,L-PNI/H-RDW 组的 1 年 ACM 风险最高[风险比(HR)=8.85,95%置信区间(CI):5.96-13.15, = 0.020],其次是 L-PNI/L-RDW(HR=3.96,95%CI:2.60-6.00,<0.001)和 H-RDW/H-PNI 组(HR=3.00,95%CI:1.99-4.50,<0.001)。制定了列线图来预测 1 年 ACM 和 MACCEs 的概率。

结论

L-PNI 和 H-RDW 的 CAD 患者预后最差。PNI 和 RDW 的组合是 1 年 ACM 的强有力预测因子。PNI 和 RDW 的共存似乎具有协同作用,为 CAD 患者的风险分层提供了更多信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db1/11434894/af4f65752dc4/nutrients-16-03176-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db1/11434894/848463731feb/nutrients-16-03176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db1/11434894/89f1cc60e64f/nutrients-16-03176-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db1/11434894/1c527bd99328/nutrients-16-03176-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db1/11434894/720faaad247f/nutrients-16-03176-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db1/11434894/11d5213994d3/nutrients-16-03176-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db1/11434894/af4f65752dc4/nutrients-16-03176-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db1/11434894/848463731feb/nutrients-16-03176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db1/11434894/89f1cc60e64f/nutrients-16-03176-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db1/11434894/1c527bd99328/nutrients-16-03176-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db1/11434894/720faaad247f/nutrients-16-03176-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db1/11434894/11d5213994d3/nutrients-16-03176-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7db1/11434894/af4f65752dc4/nutrients-16-03176-g006.jpg

相似文献

1
The Combination Effect of the Red Blood Cell Distribution Width and Prognostic Nutrition Index on the Prognosis in Patients Undergoing PCI.红细胞分布宽度与预后营养指数联合对 PCI 患者预后的影响。
Nutrients. 2024 Sep 19;16(18):3176. doi: 10.3390/nu16183176.
2
Prognostic Nutritional Index as a Novel Predictor of Long-Term Prognosis in Patients with Coronary Artery Disease After Percutaneous Coronary Intervention.预后营养指数作为经皮冠状动脉介入治疗后冠心病患者长期预后的新预测指标。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221103271. doi: 10.1177/10760296221103271.
3
Red blood cell distribution width and long-term outcome in patients undergoing percutaneous coronary intervention in the drug-eluting stenting era: a two-year cohort study.药物洗脱支架时代接受经皮冠状动脉介入治疗患者的红细胞分布宽度与长期预后:一项为期两年的队列研究
PLoS One. 2014 Apr 10;9(4):e94887. doi: 10.1371/journal.pone.0094887. eCollection 2014.
4
Association of inflammatory markers based on routine blood with prognosis in patients underwent percutaneous coronary intervention.基于常规血液的炎症标志物与行经皮冠状动脉介入治疗患者预后的关系。
Medicine (Baltimore). 2024 May 10;103(19):e38118. doi: 10.1097/MD.0000000000038118.
5
Relationship between the prognostic nutritional index and long-term clinical outcomes in patients with stable coronary artery disease.稳定型冠状动脉疾病患者的预后营养指数与长期临床结局的关系
J Cardiol. 2018 Aug;72(2):155-161. doi: 10.1016/j.jjcc.2018.01.012. Epub 2018 Mar 2.
6
Red blood cell distribution width as long-term prognostic markers in patients with coronary artery disease undergoing percutaneous coronary intervention.红细胞分布宽度作为经皮冠状动脉介入治疗的冠心病患者的长期预后标志物。
Lipids Health Dis. 2019 Jun 12;18(1):140. doi: 10.1186/s12944-019-1082-8.
7
Combination of the glycated hemoglobin levels and prognostic nutritional index as a prognostic marker in patients with acute coronary syndrome and type 2 diabetes mellitus.糖化血红蛋白水平与预后营养指数联合作为急性冠状动脉综合征合并 2 型糖尿病患者的预后标志物。
Lipids Health Dis. 2024 Jan 11;23(1):12. doi: 10.1186/s12944-023-01992-z.
8
Association between extremely high prognostic nutritional index and all-cause mortality in patients with coronary artery disease: secondary analysis of a prospective cohort study in China.极高预后营养指数与冠心病患者全因死亡率的相关性:中国前瞻性队列研究的二次分析。
BMJ Open. 2024 Jun 16;14(6):e079954. doi: 10.1136/bmjopen-2023-079954.
9
Biomarkers for risk stratification in secondary cardiovascular prevention. A role of red blood cell distribution width and calcium score.继发性心血管预防中风险分层的生物标志物。红细胞分布宽度和钙评分的作用。
Atherosclerosis. 2016 Mar;246:57-62. doi: 10.1016/j.atherosclerosis.2015.12.041. Epub 2015 Dec 29.
10
High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study.高中性粒细胞与淋巴细胞比值与 2 型糖尿病患者经皮冠状动脉介入治疗预后不良相关:一项大规模队列研究。
Cardiovasc Diabetol. 2022 Aug 13;21(1):156. doi: 10.1186/s12933-022-01583-9.

本文引用的文献

1
Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice.血清白蛋白水平:一种可在临床实践中用于不同疾病背景下重新定位的生物标志物。
J Clin Med. 2023 Sep 17;12(18):6017. doi: 10.3390/jcm12186017.
2
Prognostic impact of malnutrition in patients with coronary artery disease: a systematic review and meta-analysis.营养不良对冠心病患者预后的影响:系统评价和荟萃分析。
Nutr Rev. 2024 Aug 1;82(8):1013-1027. doi: 10.1093/nutrit/nuad108.
3
The prognostic nutritional index predicts all-cause mortality in critically ill patients with acute myocardial infarction.
预后营养指数可预测急性心肌梗死后危重症患者的全因死亡率。
BMC Cardiovasc Disord. 2023 Jul 4;23(1):339. doi: 10.1186/s12872-023-03350-4.
4
Prognostic nutritional index and prognosis of patients with coronary artery disease: A systematic review and meta-analysis.预后营养指数与冠状动脉疾病患者的预后:一项系统评价和荟萃分析。
Front Nutr. 2023 Mar 16;10:1114053. doi: 10.3389/fnut.2023.1114053. eCollection 2023.
5
Prevalence and prognostic significance of malnutrition in patients with acute coronary syndrome treated with percutaneous coronary intervention.经皮冠状动脉介入治疗的急性冠状动脉综合征患者的营养状况及预后意义。
Medicine (Baltimore). 2022 Aug 26;101(34):e30100. doi: 10.1097/MD.0000000000030100.
6
Prognostic Nutritional Index as a Novel Predictor of Long-Term Prognosis in Patients with Coronary Artery Disease After Percutaneous Coronary Intervention.预后营养指数作为经皮冠状动脉介入治疗后冠心病患者长期预后的新预测指标。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221103271. doi: 10.1177/10760296221103271.
7
Value of the prognostic nutritional index (PNI) in patients with newly diagnosed, CD5-positive diffuse large B-cell lymphoma: A multicenter retrospective study of the Huaihai Lymphoma Working Group.初诊 CD5 阳性弥漫大 B 细胞淋巴瘤患者预后营养指数(PNI)的价值:淮海淋巴瘤工作组的一项多中心回顾性研究。
Cancer. 2022 Oct 1;128(19):3487-3494. doi: 10.1002/cncr.34405. Epub 2022 Aug 6.
8
Prognostic Potential of the Controlling Nutritional Status (CONUT) Score in Predicting All-Cause Mortality and Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Meta-Analysis.控制营养状况(CONUT)评分在预测冠心病患者全因死亡率和主要不良心血管事件中的预后潜力:一项荟萃分析
Front Nutr. 2022 May 9;9:850641. doi: 10.3389/fnut.2022.850641. eCollection 2022.
9
Low serum albumin: A neglected predictor in patients with cardiovascular disease.血清白蛋白水平低:心血管疾病患者被忽视的预测因子。
Eur J Intern Med. 2022 Aug;102:24-39. doi: 10.1016/j.ejim.2022.05.004. Epub 2022 May 7.
10
Red Cell Distribution Width and Mortality in Patients Undergoing Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗患者的红细胞分布宽度与死亡率
Biomedicines. 2021 Dec 26;10(1):45. doi: 10.3390/biomedicines10010045.